Amblyopia (lazy-eye) and Neurovision treatment
Lazy-eye (amblyopia) is the development in one eye or both eyes of decreased visual acuity which does not improve with the use of glasses or contact lenses. If the development of normal vision is prevented in early childhood, in other words, if the eye does not learn to see, then amblyopia occurs. An eye that develops amblyopia will have life-long low vision. The most common causes of amblyopia are strabismus or a large difference in the visual acuity between both eyes. The basis of amblyopia treatment is to ensure babies have suitable glasses and patching of the good eye to force the lazy eye to work.
Occlusion therapy (patching) is not effective in children older than 7 years. Neurovision treatment is the only option for older children and adults. Neurovision is a method, approved by the United States Food and Drug Administration (FDA), which has been proved to be effective in the treatment of amblyopia. Treatment is carried out using a program that is installed on your computer system and initiated by your doctor. This treatment, which can be used on people with suitable eye structure and between the ages of 9 to 55, uses computer technology to re-teach the brain to see. Effective visual warnings sent to the eye, stimulate the brain cells which are responsible for sight in the primary visual cortex , this increases sensitivity to contrast, visual acuity and quality of vision.
The patient must be older than 9 years of age and must have pre-treatment vision of more than 20%. The treatment consists of approximately 40 sessions, applied every other day, 3 days a week with each session lasting on average 30-40 minutes.Results are obtained within 3-4 months. The first session takes place in hospital, but after the patient has been educated, the remainder of the treatment can be applied at home or work using the computer programme provided. After 1-2 sessions of treatment the patient’s personal treatment program is automatically prepared, according to the patients level of visibility. The system creates patient-specific assignments for the next session. The patient visits the doctor for a check-up at regular intervals during treatment. At the end of the 3-4 month period, when treatment is completed, visual acuity is improved by a few degrees.